Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan midodrine HCl 5 mg
tablets to Roberts ProAmatine® 5 mg tablets following a single, oral 5 mg (1 x 5 mg) dose
administration under fasting conditions.